MBCL-50. DISMAL OUTCOME OF HIGH RISK MEDULLOBLASTOMA TREATED WITH CHEMOTHERAPY FIRST APPROACH IN MALAYSIA

INTRODUCTION: Patients with high risk medulloblastoma are treated either with high dose chemotherapy or hyperfractionated radiotherapy. Both approaches are not feasible in resource-limited countries. POG9031 trial has reported favourable outcome for high risk medulloblastoma using standard chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Quah, Shiao Wei, Rahman, E J Abdul, Ibrahim, H Mohd, Muda, Z, Othman, I S, Unni, M N Mohamed, Gunasagaran, K, Ang, M P, Goh, C B, Teh, K H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715103/
http://dx.doi.org/10.1093/neuonc/noaa222.519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715103/
http://dx.doi.org/10.1093/neuonc/noaa222.519

Ejemplares similares